One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
QS-7 is a water-soluble triterpene saponin purified from the bark of the South American saponaria tree. Globally, the saponin extract QS-7 is currently used in five approved human recombinant protein vaccine products. It has been shown to be the gold standard adjuvant molecule for inducing favorable immune responses. There are also dozens of vaccine products containing this adjuvant molecule under development. However, since this substance is a natural product, it has been facing problems such as restricted sources and extremely difficult to control quality stability, which have limited its application in China.GC BIOTECH guarantees the source of natural materials in a variety of ways to meet the R&D and production needs of domestic enterprises.GC BIOTECH's QS-7 starts from the raw material of the bark of the tree, and then completes the purification under the condition of strict quality control at each step. GC BIOTECH QS-7 is purified under strict quality control conditions at each step of the process to ensure that GC BIOTECH QS-7 meets the pharmacopoeial quality standards.
Mechanism of action
QS-7 possesses a range of cross-activating capabilities, particularly targeting key cell populations that play a role in the acquired immune response, thus inducing the production of potent antibodies and cell-mediated immune responses, thereby enhancing the effectiveness of the vaccine. As a semi-hydrophilic surfactant, QS-7 stimulates the activation of the following processes in antigen-presenting cells, antigen phagocytosis, processing and cross-presentation via MHC. At the same time, QS-7 directly activates T cells through CD2 receptor stimulation, which in turn generates Th1-related cytokine secretion.
Application Examples
QS-7 has also been shown to increase the immunogenicity of a variety of antigens, including proteins, glycoproteins, and polysaccharides, in animal models, so it has a wide range of applications. It is currently used in a range of immunotherapeutic vaccines, such as those against tumors (melanoma, brain tumors, breast, uterine and lung cancer), neurodegenerative diseases, and infectious diseases.
Human vaccines must use high quality QS-7, which can be used alone or in as part of a formulation.
For example:
1) by forming formulations with liposomes or bisphospholipids; 2) by neutralizing surface activity and thus improving tolerance; 3) by enhancing stability in alkaline environments and maintaining high adjuvant properties in the final vaccine product.
Suggested Dosage: Mouse 10-20μg; Guinea pig 25-50μg; Rabbit/Monkey: 50-100μg.
Product Information:
Product Name: QS-7
Product Code：GC07005
Grade: GLP grade, GMP grade
Packing specification: 5mg/vial, 100mg/vial (customized service available)
Audited Supplier
Pharma Sources Insight January 2025
